EUVIMEDEUVIMED entdecken
Open Access

Hematopoietic loss of Y chromosome activates immune checkpoints and contributes to impaired senescent cell clearance and renal disease

Yohei Arai iD, Nicholas W Chavkin iD, Yuka Arai, Jonatan Halvardson iD, Josefin Bjurling iD, Heather Doviak iD, Jesse D Cochran iD, Megan A Evans, Keita Horitani iD, Yoshimitsu Yura iD, Emiri Miura-Yura iD, Soichi Sano iD und 2 weitere

Science Translational Medicine · 2025

DOI: 10.1126/scitranslmed.adv4071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, 2025. Verfasst von Yohei Arai und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Medicine, Robert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, VA 22903, USA. Hauptthemen laut MEDLINE: Cellular Senescence, Kidney Diseases, Hematopoiesis, Y Chromosome. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIA NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The accumulation of senescent cells contributes to morbidity and mortality; however, common mechanisms underpinning this age-associated phenomenon remain elusive. Hematopoietic loss of the Y chromosome (LOY) is the most frequently acquired somatic mutation in males, and this condition has been associated with various age-associated diseases and reduced lifespan. Therefore, we investigated the role of hematopoietic LOY in promoting cellular senescence, focusing on kidney disease because of its well-documented connection with aging and senescence. Herein, a prospective cohort study revealed that LOY in blood is associated with an increased incidence of kidney diseases. Analyses of transcriptional signatures in human kidneys found that immune cell LOY is enriched in patients with kidney disease and associated with greater amounts of cellular senescence. In male mice reconstituted with bone marrow lacking the Y chromosome, renal dysfunction was accompanied by senescent cell accumulation in models of kidney injury and advanced age. Treatment with a senolytic agent promoted senolysis and preferentially inhibited the progression of renal dysfunction in LOY mice. Hematopoietic LOY led to up-regulation of multiple immune inhibitory receptors, and treatment with the combination of antibodies targeting PD-1 (programmed cell death protein 1) and SIRPα (signal regulatory protein α) reduced senescent cell accumulation and rescued the renal pathology conferred by hematopoietic LOY in the kidney injury model. Collectively, these data indicate that hematopoietic LOY contributes to pathological conditions by impairing the clearance of senescent cells through up-regulation of immune checkpoint proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceKidney DiseasesHematopoiesisY ChromosomeChromosomes, Human, YAnimalsHumansMaleMiceKidneyProgrammed Cell Death 1 ReceptorAgingMice, Inbred C57BL

Substanzen

Programmed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Cardiovascular Medicine, Robert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, VA 22903, USA.
  • Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA 98101, USA.
  • Division of Cardiology, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98105, USA.
  • Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, 75108 Uppsala, Sweden.
  • Laboratory of Cardiovascular Mosaicism, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.

ORCID-Profile: Yohei Arai, Nicholas W Chavkin, Jonatan Halvardson, Josefin Bjurling, Heather Doviak, Jesse D Cochran, Keita Horitani, Yoshimitsu Yura, Emiri Miura-Yura, Soichi Sano, Lars A Forsberg, Kenneth Walsh

Förderung

  • NIGMS NIH HHS
  • NIA NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Arai, Y., Chavkin, N. W., Arai, Y., Halvardson, J., Bjurling, J., Doviak, H., Cochran, J. D., Evans, M. A., Horitani, K., Yura, Y., Miura-Yura, E., Sano, S., Forsberg, L. A., & Walsh, K. (2025). Hematopoietic loss of Y chromosome activates immune checkpoints and contributes to impaired senescent cell clearance and renal disease. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.adv4071

Vancouver

Arai Y, Chavkin NW, Arai Y, Halvardson J, Bjurling J, Doviak H, et al. Hematopoietic loss of Y chromosome activates immune checkpoints and contributes to impaired senescent cell clearance and renal disease. Science Translational Medicine. 2025. doi:10.1126/scitranslmed.adv4071

BibTeX
@article{Arai2025,
  author = {Arai, Yohei and Chavkin, Nicholas W and Arai, Yuka and Halvardson, Jonatan and Bjurling, Josefin and Doviak, Heather and Cochran, Jesse D and Evans, Megan A and Horitani, Keita and Yura, Yoshimitsu and Miura-Yura, Emiri and Sano, Soichi and Forsberg, Lars A and Walsh, Kenneth},
  title = {Hematopoietic loss of Y chromosome activates immune checkpoints and contributes to impaired senescent cell clearance and renal disease},
  journal = {Science Translational Medicine},
  year = {2025},
  doi = {10.1126/scitranslmed.adv4071}
}
Kostenlos starten →